Quantitative analysis of cerebellar lobulation in normal and agranular rats.
Cerebellar pattern formation was investigated in rats treated with DNA modifying agents. Animals were subjected to combinations of daily injections of methylazoxymethanol acetate (MAM) for the last 6 days gestation and/or localised X-irradiation of the hindbrain on postnatal days 1 and 5 (P1 and P5). Animals were analysed on embryonic day 18 (E18), P0, P3, P7, and P14. Five parameters of the cerebellum were recorded from midsagittal sections: the number of primary lobules; the thickness of the external germinal layer (EGL); the density of cells in the internal granule cell layer (IGL) region; and the midsagittal area and perimeter. In addition, the laterolateral cerebellar distance was calculated. The data demonstrate that pre- and postnatal reduction of the EGL results in reduced cerebellar growth and folding. Cessation of the treatment at birth results in a recovery and eventual overproduction of EGL, but cerebellar growth and the development of fissures lags behind that of normal rats. Pre- and postnatal destruction of the EGL severely limited cerebellar growth and fissuration, and the cerebella contained only five primary lobules at P14. Rats subjected to postnatal X-irradiation alone had a similar low density of granule cells relative to those treated with a combination of prenatal MAM injections and postnatal X-irradiation, and yet the cerebella contained deeper fissures and more lobules (nine at P14). The data indicate that there are two phases of cerebellar folding: the establishment of five lobules that arise independent of granule cell production, and the granule cell-dependent expansion and partitioning of these five principal lobules during postnatal development. We propose that the lack of correlation between the severity of the granule cell loss and degree of lobulation in agranular rats indicates that granule cells exert an inductive influence over lobulation that is in part independent of the forces generated by their production and differentiation.
Doughty
M L
ML
Laboratoire de Neurobiologie du Développement, Institut des Neurosciences (URA CNRS 1488), Université P. et M. Curie, Paris, France. martin.doughty@snv.jussieu.fr
Delhaye-Bouchaud
N
N
Mariani
J
J
D000014:Abnormalities, Drug-Induced / Q000473:pathology*; D000477:Alkylating Agents; D000818:Animals; D002526:Cerebellar Diseases / Q000139:chemically induced / Q000473:pathology*; D002531:Cerebellum / Q000196:embryology* / Q000473:pathology* / Q000528:radiation effects; D005260:Female; D008297:Male; D008746:Methylazoxymethanol Acetate / Q000031:analogs & derivatives; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011833:Radiation Injuries, Experimental / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar / Q000196:embryology*
D000477:Alkylating Agents; D008746:Methylazoxymethanol Acetate; C030667:methylazoxymethanol